Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada

In British Columbia, Canada, initial growth of the SARS-CoV-2 Delta variant was slower than that reported in other jurisdictions. Delta became the dominant variant (>50% prevalence) within ≈7–13 weeks of first detection in regions within the United Kingdom and United States. In British Columbia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Y.L. Elaine, Irvine, Michael A., Prystajecky, Natalie, Sbihi, Hind, Taylor, Marsha, Joffres, Yayuk, Schertzer, Andrea, Rose, Caren, Dyson, Louise, Hill, Edward M., Tildesley, Michael, Tyson, John R., Hoang, Linda M.N., Galanis, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521616/
https://www.ncbi.nlm.nih.gov/pubmed/37640374
http://dx.doi.org/10.3201/eid2910.230055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521616/
https://www.ncbi.nlm.nih.gov/pubmed/37640374
http://dx.doi.org/10.3201/eid2910.230055

Ejemplares similares